NO20000373D0 - Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmåte for deres fremstilling og farmasoeytiske sammensetninger inneholdende dem - Google Patents

Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmåte for deres fremstilling og farmasoeytiske sammensetninger inneholdende dem

Info

Publication number
NO20000373D0
NO20000373D0 NO20000373A NO20000373A NO20000373D0 NO 20000373 D0 NO20000373 D0 NO 20000373D0 NO 20000373 A NO20000373 A NO 20000373A NO 20000373 A NO20000373 A NO 20000373A NO 20000373 D0 NO20000373 D0 NO 20000373D0
Authority
NO
Norway
Prior art keywords
alkyl
indole
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20000373A
Other languages
English (en)
Other versions
NO314801B1 (no
NO20000373L (no
Inventor
Gilbert Lavielle
Olivier Muller
Bernard Cimetiere
Mark Millan
Alain Gobert
Jean-Michel Rivet
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20000373D0 publication Critical patent/NO20000373D0/no
Publication of NO20000373L publication Critical patent/NO20000373L/no
Publication of NO314801B1 publication Critical patent/NO314801B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20000373A 1999-01-26 2000-01-25 Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser og farmasöytiske sammensetninger inneholdende dem NO314801B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900801A FR2788772B1 (fr) 1999-01-26 1999-01-26 Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20000373D0 true NO20000373D0 (no) 2000-01-25
NO20000373L NO20000373L (no) 2000-07-27
NO314801B1 NO314801B1 (no) 2003-05-26

Family

ID=9541208

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000373A NO314801B1 (no) 1999-01-26 2000-01-25 Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser og farmasöytiske sammensetninger inneholdende dem

Country Status (22)

Country Link
US (1) US6239129B1 (no)
EP (1) EP1023898B1 (no)
JP (1) JP2000212162A (no)
KR (1) KR100445389B1 (no)
CN (1) CN1155570C (no)
AT (1) ATE234093T1 (no)
AU (1) AU761084B2 (no)
BR (1) BR0000158A (no)
CA (1) CA2297279C (no)
DE (1) DE60001591T2 (no)
DK (1) DK1023898T3 (no)
EA (1) EA003146B1 (no)
ES (1) ES2193923T3 (no)
FR (1) FR2788772B1 (no)
HK (1) HK1029584A1 (no)
HU (1) HUP0000308A2 (no)
MX (1) MXPA00000856A (no)
NO (1) NO314801B1 (no)
NZ (1) NZ502494A (no)
PL (1) PL338027A1 (no)
SI (1) SI1023898T1 (no)
ZA (1) ZA200000336B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001247562A (ja) * 2000-03-07 2001-09-11 Daicel Chem Ind Ltd アミド化合物及びその製造方法
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
DE60142355D1 (de) * 2000-11-20 2010-07-22 Biovitrum Ab Publ Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
EE200300478A (et) * 2001-03-29 2003-12-15 Bristol-Myers Squibb Company Tsüklopropüülindooli derivaadid kui selektiivsed serotoniini tagasihaarde inhibiitorid
WO2004026830A1 (en) * 2002-09-17 2004-04-01 F. Hoffmann-La Roche Ag 2,7-substituted indoles and their use as 5-ht6 modulators
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
WO2005056522A2 (en) * 2003-12-04 2005-06-23 National Health Research Institutes Indole compounds
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
TW270114B (no) * 1993-10-22 1996-02-11 Hoffmann La Roche
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
AU5343298A (en) * 1997-01-13 1998-08-03 Yamanouchi Pharmaceutical Co., Ltd. 5-ht2c receptor agonists and aminoalkylindazole derivatives

Also Published As

Publication number Publication date
JP2000212162A (ja) 2000-08-02
EA200000068A3 (ru) 2000-10-30
FR2788772A1 (fr) 2000-07-28
FR2788772B1 (fr) 2001-03-02
KR100445389B1 (ko) 2004-08-25
KR20010006587A (ko) 2001-01-26
NO314801B1 (no) 2003-05-26
PL338027A1 (en) 2000-07-31
NZ502494A (en) 2001-06-29
DK1023898T3 (da) 2003-06-10
ZA200000336B (en) 2000-08-15
BR0000158A (pt) 2000-09-19
DE60001591T2 (de) 2003-12-24
NO20000373L (no) 2000-07-27
EA003146B1 (ru) 2003-02-27
HK1029584A1 (en) 2001-04-06
DE60001591D1 (de) 2003-04-17
CA2297279C (fr) 2004-05-18
EP1023898A1 (fr) 2000-08-02
CN1155570C (zh) 2004-06-30
ES2193923T3 (es) 2003-11-16
EP1023898B1 (fr) 2003-03-12
ATE234093T1 (de) 2003-03-15
SI1023898T1 (en) 2003-06-30
CA2297279A1 (fr) 2000-07-26
HU0000308D0 (en) 2000-03-28
US6239129B1 (en) 2001-05-29
HUP0000308A2 (en) 2002-06-29
AU761084B2 (en) 2003-05-29
CN1266057A (zh) 2000-09-13
AU1355300A (en) 2000-07-27
EA200000068A2 (ru) 2000-08-28
MXPA00000856A (es) 2002-03-08

Similar Documents

Publication Publication Date Title
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
AR049418A1 (es) Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes.
DK0513379T3 (da) 2-Arylthiazolderivater og farmaceutisk præparat indeholdende sådanne
NO981415D0 (no) Nye N-arylpiperidin-forbindelser, en fremgangsmåte ved fremstilling derav og farmasöytiske preparater inneholdende slike
AU9079198A (en) Indolecarboxylic compounds and their use as pharmaceutical compounds
NO20000373D0 (no) Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmåte for deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
NO20001402L (no) Substituerte kromanderivater
NO20016389L (no) Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav
PT1216245E (pt) Derivados sulfonil-hidrazida farmaceuticamente activos
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
BR0208823A (pt) Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
NO962360D0 (no) Nye indol, indazol-og benzisoksazolforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20002351L (no) Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
UA89619C2 (ru) Соединения пиперазина, способ их получения и фармацевтическая композиция, которая их содержит
IS2282B (is) Ný lyfefnasambönd með alfa2viðtakavirkni
NO20051794L (no) Fremgangsmate for fremstilling av epotilonderivater, og nye mellomprodukter for fremgangsmaten, samt fremgangsmater for fremstilling av slike
NO984007L (no) Nye disubstituerte trans-3,4,4a,5,6,10b-heksahydro-2H-naft[1,2-b]-1,4-oksaziner, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholder disse
NO20002315L (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO20045540L (no) Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem
NO955071L (no) abeo-Ergolin-derivater som 5HT1A-ligander
NO303494B1 (no) Tetrahydronaftalenderivater, fremgangsmÕte for deres fremstilling og farmas°ytisk preparat inneholdende et slikt derivat, samt mellomprodukter
DK0570263T3 (da) Hidtil ukendte alkencarboxylsyrederivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder